Brief Summary
Type:
Leukemias
Study Type:
Treatment
Phase:
I
ClinicalTrials.gov Identifier:
NCT06177067
Study #:
CMH - RAVAML
Start Date:
Feb 05, 2025
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT06177067
View Complete Trial Details & Eligibility at ClinicalTrials.gov
